Document:

EMR Technology Solutions, Inc. - 10-12G/A

Exhibit 4.3

 

THIS
NOTE AND THE SHARES OF COMMON STOCK ACQUIRABLE ON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, AND MAY NOT BE SOLD, OFFERED FOR SALE, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR
AN OPINION OF COUNSEL, WHICH COUNSEL AND OPINION SHALL BE SATISFACTORY TO THE CORPORATION, THAT SUCH REGISTRATION IS NOT REQUIRED.

 

CONVERTIBLE PROMISSORY NOTE

 

	***$200,000.00***	BEDMINSTER, NEW JERSEY

 

FOR VALUE RECEIVED, the undersigned,
EMR TECHNOLOGY SOLUTIONS, INC., a Nevada corporation (the “Corporation”), agrees and promises to pay to the order of
Susan Turcotte (the “Holder”), at 6060 Anchorline Court, North Fort Myers, FL 33917, or at such other place or places as
the Holder may designate in writing, the principal amount of TWO HUNDRED THOUSAND ($200,000) DOLLARS, as follows:

 

1.       Interest
Only Payments. Commencing on the last day at the end of the first (1st) quarter following the Closing contemplated by the
Purchase Agreement between the Corporation, the Holder, and EMRgence, LLC and on the same day of the next three (3) consecutive
quarters thereafter, the Corporation shall make an interest payment calculated at the rate of six (6.00%) percent per annum on
the outstanding principal balance.

 

2.       Principal
Reduction. Commencing on December 31, 2017, the Corporation shall repay the principal, together with interest calculated
at 6.00% per annum on the principal remaining from time-to-time unpaid, in eight (8) equal quarterly installments calculated to
repay the outstanding principal in full by thirty-six (36) months following the Closing. Interest shall be computed on the basis
of a year consisting of twelve (12) months of thirty (30) days each. All payments shall be made in lawful money of the United States
of America. Payment shall be credited first to the accrued interest then due and payable and the remainder applied to principal.

 

3.       Prepayment.
The Corporation may, at its option, prepay this Note, in whole or in part, at any time prior to the Maturity Date, without
penalty. Any prepayment shall first be applied to any outstanding interest due and payable, then to the principal balance in the
inverse order of payment.

 

4.       Credits
and Adjustments. The principal amount of this Note shall be subject to certain credits and adjustments in accordance with
Section 4(b) of a certain Purchase Agreement dated of even date herewith. Negative adjustments pursuant to Section 4(b)(iii) of
the Purchase Agreement shall be treated as a credit against principal payments due hereunder, but in the inverse order of such
payments. The principal balance of this Note shall also serve as a fund to secure Seller’s indemnification obligations under
Section 14 of the Purchase Agreement.

 

    	 		PROMISSORY NOTE

     

    

 

5.       Late
Payments; Default Rate. If the Corporation fails to make any payment of principal, interest or other amount coming
due pursuant to the provisions of this Note within ten (10) calendar days of the date due and payable, the Corporation also
shall pay to the Holder a late charge equal to five percent (5%) of the amount of such payment. Such five day period shall
not be construed in any way to extend the due date of any such payment. The late charge is imposed for the purpose of
defraying the Holder’s expenses incident to the handling of delinquent payments and is in addition to, and not in lieu
of, the exercise by the Holder of any rights and remedies hereunder, under the other Loan Documents or under applicable laws,
and any fees and expenses of any agents or attorneys which the Holder may employ. Upon maturity, whether by acceleration,
demand or otherwise, and at the option of the Holder upon the occurrence of any Event of Default (as hereinafter defined) and
during the continuance thereof, this Note shall bear interest at a rate of 6% per annum (based on a year of 360 days and
actual days elapsed) but not more than the maximum rate allowed by law (the “Default Rate”). The Default Rate shall
continue to apply whether or not judgment shall be entered on this Note.

 

6.       Events
of Default. The occurrence of any of the following events will be deemed to be an “Event of Default” under this
Note: (i) the nonpayment of any principal, interest or other indebtedness under this Note within ten (10) days of written notice
of default; (ii) the occurrence of any event of default or default and the lapse of any notice or cure period under any Loan Document;
(iii) the filing by or against the Corporation of any proceeding in Bankruptcy, receivership, insolvency, reorganization, liquidation,
conservatorship or similar proceeding (and, in the case of any such proceeding instituted against the Corporation, such proceeding
is not dismissed or stayed within thirty (30) days of the commencement thereof); (iv) any assignment by the Corporation for the
benefit of creditors, or any levy, garnishment, attachment or similar proceeding is instituted against any property of the Corporation
held by or deposited with the Lender; (v) the commencement of any foreclosure or forfeiture proceeding, execution or attachment
against any collateral securing the obligations of the Corporation to the Holder; or (vi) the Corporation ceases doing business
as a going concern.

 

Upon the
occurrence of an Event of Default: (a) If an Event of Default specified in clause (iii) or (iv) above shall occur, the
outstanding principal balance and accrued interest hereunder together with any additional amounts payable hereunder shall be
immediately due and payable without demand or notice of any kind; (b) if any other Event of Default shall occur, the
outstanding principal balance and accrued interest hereunder together with any additional amounts payable hereunder, at the
option of the Holder and without demand or notice of any kind, may be accelerated and become immediately due and payable; (c)
at the option of the Holder, this Note will bear interest at the Default Rate from the date of the occurrence of the Event of
Default; and (d) the Holder may exercise from time to time any of the rights and remedies available to the Holder under the
Loan Documents or under applicable law.

 

7.       Miscellaneous.
No delay or omission of the Holder to exercise any right or power arising hereunder shall impair any such right or power or
be considered to be a waiver of any such right or power, nor shall the Holder’s action or inaction impair any such right
or power. The Corporation agrees to pay on demand, to the extent permitted by law, all costs and expenses incurred by the Holder
in the enforcement of its rights in this Note and in any security therefor, including without limitation reasonable fees and expenses
of the Holder’s counsel. If any provision of this Note is found to be invalid by a court, all the other provisions of this
Note will remain in full force and effect. The Corporation hereby forever waives presentment, protest, notice of dishonor and notice
of non-payment. The Corporation also waives all defenses based on suretyship or impairment of collateral. This Note shall bind
the Corporation and its heirs, executors, administrators, successors and assigns of the Corporation
and the benefits hereof shall inure to the benefit of the Holder and its successors and assigns.

 

    	 	 2	PROMISSORY NOTE

     

    

 

8.       No
Setoff. The obligations of the Corporation to pay the principal balance and interest due to the Holder shall be absolute
and unconditional, and the Corporation shall make such payment without abatement, diminution or deduction regardless of any cause
or circumstances whatsoever, including, without limitation, any defense, setoff, recoupment, or counterclaim which the Corporation
may have or assert against the Holder or any other person, except as provided for in Paragraph 4 of this Note.

 

9.       Conversion.
The Holder may, at any time prior to the Maturity Date, convert the remaining principal balance of this Note, plus any
accrued interest, or any portion thereof, into fully paid and nonassessable shares of the common stock, no par value, of the Corporation
(the “Common Stock”), on the basis of one share of such stock for each Three Dollars ($3.00) (the “Conversion Price”)
in unpaid principal and/or interest. Such conversion shall be effected by the surrender of this Note at the principal office of
the Corporation (or such other office or agency of the Corporation in the continental United States as the Corporation may designate
by notice in writing to the Holder) at any time during usual business hours, together with notice in writing that the Holder wishes
to convert a portion or all of this Note, which notice shall also state the name(s) (with addresses) and denominations in which
the certificate(s) for Common Stock shall be issued and shall include instructions for delivery thereof. Such conversion shall
be deemed to have been effected as of the close of business on the date on which this Note shall have been surrendered and such
notice shall have been received, and at such time (the “Voluntary Conversion Date”) the rights of the Holder with respect
to the principal amount of the Note converted shall cease and the person(s) in whose name(s) any certificate(s) for Common Stock
are to be issued upon such conversion shall be deemed to have become the holder or holders of record of the shares of Common Stock
represented by such certificate(s). As soon as practicable after the Voluntary Conversion Date, the Corporation shall deliver to,
or as directed by, the Holder, certificates representing the number of shares of Common Stock issuable by reason of such conversion
registered in such name or names and such denomination or denominations as the Holder shall have specified, together with cash
as provided in Section 13 in respect of any fraction of a share of such stock otherwise issuable upon such conversion. In each
case of conversion of this Note in part only, the Corporation shall receive and hold this Note as a fiduciary agent of the Holder,
shall endorse on this Note the date and amount of this Note so converted, and such amount shall be deemed no longer outstanding.
Upon such endorsement, the Corporation shall promptly return this Note to the Holder.

 

10.       Reservation of Common Stock.

 

(a)       The
Corporation will at all times from and after this date reserve and keep available out of its authorized but unissued shares of
Common Stock or its treasury shares, or otherwise, solely for the purpose of issuance upon the conversion of this Note, such number
of shares of Common Stock as shall then be issuable upon the conversion of this Note. The Corporation covenants that all shares
of Common Stock which shall be so issuable shall, when issued, be duly and validly issued, fully paid and nonassessable and free
from all taxes, liens and charges.

 

    	 	 3	PROMISSORY NOTE

     

    

 

(b)
     The Corporation will not take any action which would result in any adjustment of the number of shares
of Common Stock acquirable upon conversion of this Note if the total number of shares issuable after such action upon conversion
of this Note, together with the total number of shares of Common Stock then outstanding, would exceed the total number of shares
of Common Stock then authorized under the Corporation’s Certificate of Incorporation which are not reserved or required to be
reserved for any purpose other than the purpose of issue upon conversion of this Note.

 

(c)       The
issuance of certificates for shares of Common Stock upon conversion of this Note shall be made without charge to the Holder for
any issuance tax or other cost incurred by the Corporation in connection with such conversion and the related issuance of shares
of Common Stock.

 

(d)       If
any shares of Common Stock required to be reserved for purposes of conversion of this Note require, before such shares may be issued
upon conversion, registration with or approval of any governmental authority under any federal or state law (other than any registration
under the Securities Act of 1933, as then in effect, or any similar federal statute then in force, or any state securities law,
required by reason of any transfer involved in such conversion) or listing on any domestic securities exchange, the Corporation
will, at its expense and as expeditiously as possible, use its best efforts to cause such shares to be duly registered or approved
for listing or listed on such domestic securities exchange, as the case may be.

 

11.      Subdivisions and Combinations.

 

(a)       In
the event the Corporation shall at any time subdivide by any stock split its outstanding Common Stock into a greater number of
shares of such stock, the Conversion Price shall be proportionately decreased. Conversely, in the event the outstanding shares
of one or more classes of Common Stock shall at any time be combined into a smaller number of shares by a reverse stock split,
the Conversion Price shall be proportionately increased. In the case of any subdivision or combination described in this Section
11, the adjustment to be made pursuant hereto shall be made as of the close of business on the date immediately prior to the date
upon which such corporate action becomes effective.

 

(b)       No
Adjustment for Small Amounts. Notwithstanding any contrary provision of subsection (a) of this Section 11, the Corporation shall
not be required to give effect to any adjustment to the Conversion Price if the amount of such adjustment would be less than $.01,
but any such adjustment shall be carried forward and adjustment with respect thereto shall be made at the time of and together
with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward, causes a cumulative
net adjustment of $.03 or more.

 

    	 	 4	PROMISSORY NOTE

     

    

 

(c)       Organic
Changes, Etc. If any capital reorganization or reclassification of the capital stock of the Corporation (other than a change in
par value, or from par value to no par value, or from no par value to par value, or as a result of an issuance of Common Stock
by dividend or other distribution or by reason of a subdivision or combination), or any consolidation or merger of the Corporation
with or into another corporation, or any sale of all or substantially all of the Corporation’s property and assets to any person,
firm or corporation (collectively, any “Organic Change”) shall be effected in such a way that holders of Common Stock
shall be entitled to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in
exchange for Common Stock, then, as a condition to such Organic Change, lawful and adequate provision shall be made whereby the
Holders shall thereafter have the right to acquire and receive upon the basis and upon the terms and conditions specified herein
and in lieu of the shares of Common Stock of the Corporation immediately theretofore acquirable and receivable (directly or upon
subsequent conversion, assuming unrestricted convertibility) upon the conversion of this Note, such shares of stock, securities
or assets as may be issued or payable with respect to or in exchange for a number of outstanding shares of Common Stock equal
to the number of shares of Common Stock immediately theretofore acquirable and receivable (directly or upon subsequent conversion,
assuming unrestricted convertibility) upon conversion of this Note had such Organic Change not taken place (except that the terms
of the parenthetical provision at the end of the next sentence shall be applied in determining the number of shares of Common
Stock immediately theretofore acquirable and receivable). In any such case, appropriate provision shall be made with respect to
the Holder’s rights and interests to the end that the provisions contained in this Note (including without limitation provisions
for adjustments of the number of shares of Common Stock acquirable and receivable upon the exercise of the conversion rights granted
herein) shall thereafter be applicable in relation to any shares of stock, securities or assets thereafter deliverable upon the
conversion of this Note (including, in the case of any such consolidation, merger or sale in which the successor corporation or
purchasing entity is other than the Corporation, an immediate adjustment in the number of shares of Common Stock acquirable and
receivable upon conversion of this Note). In the event of a merger or consolidation of the Corporation with or into another corporation
or the sale of all or substantially all of the Corporation’s property and assets to another corporation as a result of which a
number of shares of common stock of the surviving or purchasing corporation greater or lesser than the number of shares of Common
Stock of the Corporation outstanding immediately prior to such merger, consolidation or sale are issuable to holders of Common
Stock, the aggregate number of shares of Common Stock into which this Note was convertible in effect immediately prior to such
merger, consolidation or sale shall be adjusted (pursuant to Subsection (a) of this Section 11) as though there were a subdivision
or combination of the outstanding shares of Common Stock. The provisions of this subsection (c) shall similarly apply to successive
Organic Changes.

 

12.       Notice of Adjustment.

 

(a)       Immediately
upon any adjustment in the number of shares of Common Stock acquirable and receivable upon conversion of this Note or any adjustment
or readjustment in the Conversion Price, the Corporation shall send written notice to the Holder, which notice shall set forth
in reasonable detail the method of calculation and the facts upon which such calculation is based. The Corporation shall, upon
written request at any time of any holder of the Convertible Note, furnish or cause to be furnished to such holder a similar certificate
setting forth (i) such adjustments and readjustments, (ii) the Conversion Price then in effect, and (iii) the number of shares
of Common Stock and the amount, if any, of other property which then would be received upon the conversion of the Convertible Note.
The Corporation may retain a firm of independent public accountants of recognized standing which may be the firm regularly retained
by the Corporation to make any computation required under this Section and a certificate signed by such firm shall be conclusive
evidence of the correctness of any computation made under this Section.

 

    	 	 5	PROMISSORY NOTE

     

    

 

		(b)	In the event that:

 

		(i)	there is any proposed combination or subdivision of the outstanding shares
of Common Stock;

 

		(ii)	there shall be any proposed Organic Change; or

 

		(iii)	there shall be any proposed voluntary or involuntary dissolution, liquidation
or winding up of the Corporation;

 

then in connection with each such event,
the Corporation shall send to the Holder: (A) at least sixty (60) days prior written notice of the date on which the books of the
Corporation shall close or a record shall be taken for determining voting rights in respect of such event; and (B) in the case
of any proposed Organic Change, dissolution, liquidation or winding up, at least sixty (60) days prior written notice of the date
when the same shall take place (and specifying the date on which the holders of Common Stock shall be entitled to exchange their
Common Stock for securities or other property deliverable upon such Organic Change, dissolution, liquidation or winding up).

 

13.       Fractional
Interests. The Corporation shall not be required to issue any fractional shares of Common Stock on the conversion of this
Note. If any fraction of a share of Common Stock would be issuable upon conversion of this Note, the Corporation shall purchase
such fraction for an amount in cash equal to the current market price of such fraction on the last Business Day prior to conversion.

 

14.       Voting.
Nothing contained in this Note shall be construed as conferring upon the Holder the right to vote or to consent or to receive
notice as a stockholder in respect of the meetings of stockholders for the election of directors of the Corporation or any other
matter. Notwithstanding the foregoing, the Corporation shall mail by first class to the Holder, at the address first specified
above, one copy of all materials forwarded to stockholders, said mailing to be made promptly after mailing to stockholders.

 

15.       Notices.
Any notice required or permitted by this Note shall be in writing and shall be deemed sufficient upon delivery, when delivered
personally or by a nationally-recognized delivery service (such as Federal Express or UPS), or forty-eight (48) hours after being
deposited in the U.S. mail, as certified or registered mail, with postage prepaid, addressed to the party to be notified at such
party’s address as set forth above or as subsequently modified by written notice.

 

16.       Governing
Law; Venue; Jurisdiction. This Note shall be governed by and construed in accordance with the internal laws of the State
of Florida. The Corporation hereby irrevocably submits to the exclusive jurisdiction of the federal or state court sitting in the
State of Florida over any dispute arising out of or relating to this Note. The Corporation hereby irrevocably waives, to the fullest
extent permitted by applicable law, any objection which it may now or hereafter have to the laying of venue of any such dispute
brought in such court or any defense of inconvenient forum for the maintenance of such dispute. The Corporation agrees that a judgment
in any such dispute may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. The
Corporation consents to process being served in any suit, action or proceeding hereunder by the mailing of a copy thereof in accordance
with the notice provisions of this Note.

 

    	 	 6	PROMISSORY NOTE

     

    

 

17.       Modification.
No modification or waiver of any provision of this Note, or any departure by the Corporation therefrom, shall in any event
be effective unless the same shall be in writing signed by the Holder, and then such modification or waiver shall be effective
only in the specific instance for the specific purpose given.

 

18.       Waiver
of Jury Trial. The Corporation irrevocably waives any and all rights the Corporation may have to a trial by jury in any
action, proceeding or claim of any nature relating to this note, any documents executed in connection with this note or any transaction
contemplated in any loan documents. The Corporation acknowledges that the foregoing waiver is knowing and voluntary.

 

Dated: September 26, 2016

 

	 	 	EMR Technology Solutions, Inc.
	 	 	 
	Attest:	 	 	 	 
	/s/ Lowell T. Holden	 	By:	/s/ John X. Adiletta
	Name:   Lowell T. Holden	 	 	Name:	John X. Adiletta
	Title:     Secretary	 	 	Title:	Chief Executive Officer

 

    	 	 7	PROMISSORY NOTEEMR Technology Solutions, Inc. - 10-12G/A

Exhibit 10.1

STOCK PURCHASE AGREEMENT

 

This STOCK PURCHASE
AGREEMENT is entered into as of September 23, 2016, among FIRST MEDICAL SOLUTIONS CORPORATION, a Florida Corporation (“FMS”),
DENIS SALINS (the “FMS Shareholder”) and EMR TECHNOLOGY SOLUTIONS, INC., a Nevada corporation (“EMR”).

 

WHEREAS, the respective
Board of Directors of EMR and all of the shareholders of FMS desire that FMS should be acquired by way of a purchase of all of
the issued and outstanding shares of FMS (the “Purchase”).

 

NOW, THEREFORE, in consideration of the
mutual covenants and promises contained herein, it is agreed as follows:

 

ARTICLE I

THE PURCHASE

 

1.1          Purchase
and Sale of Stock. In exchange for the consideration specified herein, including, without limitation, the payment of the Purchase
Price herein, and subject to the terms and conditions of this Agreement, EMR agrees to purchase, acquire and assume from FMS Shareholders
and the FMS Shareholder agrees to sell, assign, transfer, convey and deliver to EMR, all right, title and interest in and to the
FMS Shareholder’s shares.

 

1.2          Delivery
of Possession and Instruments of Transfer. At the Closing, the FMS Shareholder shall deliver to EMR possession of all certificates
representing all of the outstanding and issued shares of stock in FMS (the “Shares”), duly endorsed in blank or accompanied
by duly executed stock powers with signatures notarized, and such other instruments of transfer reasonably requested by and satisfactory
to EMR and its counsel for consummation of the transactions contemplated under this Agreement and as are necessary to vest in EMR,
all right, title and interest in and to the Shares free and clear of any lien, encumbrance, security agreement, equity, option,
claim, charge or restriction, other than restrictions imposed by federal or state securities laws.

 

1.3          Satisfaction
of Certain Liabilities. Notwithstanding anything to the contrary contained herein, FMS acknowledges that although EMR is acquiring
all of the outstanding capital stock of the FMS Shareholder, the FMS Shareholder has agreed that, upon the Closing Date, FMS shall
have no liabilities other than the liabilities set forth on the Financial Statements dated August 31, 2016 or arising thereafter
in the ordinary course of business

 

1.4          Closing.
The closing (the “Closing”) of the purchase and sale provided for in this Agreement shall take place simultaneously
with the execution of this Agreement. The closing of the Purchase (the “Closing”) will take place through the electronic
and overnight delivery of documents and the wire transfer of funds, on the later of one (1) business day following the satisfaction
or waiver of the conditions precedent set forth in Article V, or at such other date as the parties shall all agree (the “Closing
Date”).

 

    	 

    	 

    

 

1.5          Purchase Price, Earn Out, and Working Capital and Convertible Note Adjustment.

 

a.            Purchase of Shares. On the Effective Date, EMR shall purchase all of the FMS Shares from the FMS Shareholder for the sum of One
Million Dollars ($1,000,000) paid and/or satisfied upon the following terms:

 

b.            At
Closing, the FMS Shareholder shall be paid the sum of Two Hundred and Fifty Thousand Dollars ($250,000.00) in cash;

 

c.            At
Closing, the FMS Shareholder shall be issued 50,000 shares of the common stock of EMR;

 

d.            At
Closing, EMR shall issue a Convertible Promissory Note (the “Note”) in the principal amount of Seven Hundred Thousand
Dollars ($700,000.00) payable to the FMS Shareholder.

 

e.            The Note shall be repaid as follows:

 

		(1)	During the first twenty-four (24) months immediately following the Closing, EMR shall make interest-only
payments to the holder(s) of the Note, such payments to be made quarterly in arrears, in cash, at an annual interest rate of ten
(10%) percent;

 

		(2)	Commencing on the twenty-fifth (25th) month, the Note shall be completely amortized over the next
twelve (12) months, with payments of principal and interest to be made in four equal quarterly payments in arrears, in cash.

 

		(3)	As additional consideration for the purchase of the FMS Shares, EMR shall pay to the FMS Shareholder
an amount equal to fifteen percent (15%) of the Net Revenues, defined as gross revenues less any commissions paid to any third
parties, for a period of thirty-six (36) months, for contracts entered into by EMR with New Clients signed within one hundred twenty
(120) days after the Closing (the “Commission Payments”). “New Clients” shall mean those clients, which
have entered into contracts with EMR as a result of endorsements from medical associations given to EMR. EMR shall use its best
efforts to enter into contracts with New Clients within a commercially reasonable time after they have been demoed and have agreed
upon a price quote for the service. EMR shall pay the Commission Payments to the FMS Shareholder by the 45th day after the end
of each month for which payments have been received by EMR from the New Clients. The FMS Shareholder shall have the right to periodically
inspect the books and records of EMR in order to verify the calculation
of the Commission Payments.

 

		(4)	As further consideration for the purchase of the FMS Shares, EMR shall pay to the FMS Shareholder
an amount equal to seven and one-half percent (7.5%) of the Net Revenues, as previously defined, for a period of thirty-six (36)
months, for contracts entered into by EMR with New Clients signed within twelve (12) months following the initial 120 day period
described in Section 1.4a(2) above (the “Additional Commission Payments”).
EMR shall use its best efforts to enter into contracts with New Clients within a commercially reasonable time after they have
been demoed and have agreed upon a price quote for the service. EMR shall pay the Additional Commission Payments to the FMS Shareholder
by the 45th day after the end of each month for which such Commission Payments have been
received by EMR from the New Clients. The FMS Shareholder shall have the right to periodically inspect the books and records of
EMR in order to verify the calculation of the Additional Commission Payments.

 

    	2 

    	 

    

 

1.6          Source
Code Escrow. At or before the Closing, EMR, the FMS Shareholder, and EscrowTech International, Inc. (the “Escrow Agent”)
shall have executed and delivered a Technology Escrow Agreement (the “Escrow Agreement”), in the form attached hereto
as Exhibit “A”, pursuant to which EMR, on behalf of FMS, deposits a copy of the Source Code (the “Deposit Materials”)
with the Escrow Agent to be held by the Escrow Agent as hereinafter provided as security for payment and performance of the Note
and EMR’s obligation to make Commission Payments under Sections 1.4 (e) (3) and 1.4 (e) (4) .. “Source Code”
shall mean all source code, programming code, programing instructions, programing statements, programming text containing declarations,
instructions, functions, loops, declarations, notes, scripts, files and other statements that tells a computer program how to function,
which was created by or on behalf of FMS, and owned by FMS prior to the Closing.

 

1.7          Release
Provisions. The Escrow Agreement shall provide that the Deposit Materials shall be released in accordance with the following
procedures:

 

a.            The
Escrow Agent shall hold the Deposit Materials until the entire principal balance and all accrued interest due under the Promissory
Note is satisfied in full and those certain obligations of EMR to pay commissions to the FMS Shareholder pursuant to Sections
1.4 (e) (3) and 1.4 (e) (4) of this Agreement are satisfied in full. Upon the satisfaction of said obligations, the Deposit Materials
shall be delivered by the Escrow Agent to EMR and no copies thereof shall be retained by EscrowTech.

 

b.            An
“Event of Default” means the failure of EMR to fulfill its aforementioned obligations under Section 1.7 which would
entitle the FMS Shareholder to commence an action or to take steps to realize on any security for the payment of any of the aforementioned
obligations after the expiration of any applicable cure period.

 

c.            Upon
the occurrence of an Event of Default, and subject to the terms more particularly set forth in the Escrow Agreement, the FMS Shareholder
shall be entitled to a release of the Deposit Materials and shall have the right to possess, collect, license, use, and/or sell
the Deposit Materials, or any part thereof and the FMS Shareholder shall also be released from any prohibitions, restrictions,
and/or covenants not to compete with the business of EMR and/or FMS.

 

1.8          Working
Capital Adjustment. The Note shall subject to a downward adjustment, calculated as follows:

 

a.            In
connection with the Purchase, EMR will assume limited liabilities of FMS. The limited liabilities shall be trade accounts payable
and accrued expenses not to exceed the Current Assets of FMS at closing, that
is, a one to one ratio (1:1) of Current Assets to Total Liabilities. (Total liabilities shall not include shareholder loans any
of which will be satisfied on or before closing and not assumed by the Buyer).

 

    	3 

    	 

    

 

b.            A
downward adjustment shall be made to the Note in a sum equal to the amount by which the Total Liabilities exceed the Current Assets.
A final reconciliation of the Total Liabilities and Current Assets shall be made within ninety (90) days of the Closing.

 

ARTICLE II

REPRESENTATIONS AND WARRANTIES
OF FMS

 

Except as set forth
in the schedules to this Agreement, disclosure in any one of which shall apply to any and all representations and warranties made
in this Agreement, FMS, and the FMS Shareholder hereby represents and warrants to EMR, as of the date of this Agreement and as
of the Effective Time, as follows:

 

2.1          Organization,
Standing, Power and Authority. FMS is a corporation duly incorporated, validly existing and in good standing under the laws
of the State of Florida. FMS has corporate power and authority to conduct its business as presently conducted by it and to enter
into and perform this Agreement and to carry out the transactions contemplated by this Agreement. FMS is duly qualified to do business
as a foreign corporation doing business in each state in which it transacts business and where the failure to be so qualified and
in good standing would have a material adverse effect on FMS or its business. FMS does not have an ownership interest in any corporation,
partnership (general or limited), limited liability company or other entity, whether foreign or domestic (collectively such ownership
interests including capital stock). The execution and delivery of this Agreement, the execution and delivery of each Closing Document
to which FMS is a party, and the performance by FMS of its obligations thereunder, are within the powers of FMS, and have been
authorized by all necessary action properly taken, have received all necessary governmental approvals, if any were required, and
do not contravene or conflict with any current provision of any material law, any applicable judgment, ordinance, regulation or
order of any court or governmental agency, the Articles of Incorporation, By-Laws Shareholder Agreement of FMS or any agreement
binding upon FMS The FMS Shareholder and Officer executing this Agreement and Closing Documents are duly authorized to act on behalf
of FMS.

 

2.2          Capitalization.
There are 10,000 shares of capital stock of FMS authorized, consisting entirely of common stock, no par value. As of the date
of this Agreement, there are 10,000 FMS Shares issued and outstanding. No FMS Shares have been reserved for issuance to any person,
and there are no outstanding rights, warrants, options or agreements for the purchase of FMS Shares. All outstanding FMS Shares
are validly issued, fully paid, non-assessable, not subject to pre-emptive rights and have been issued in compliance with all state
and federal securities laws or other applicable laws.

 

    	4 

    	 

    

 

2.3          Financial Statements.

 

a.            FMS
has made available to EMR copies of its unaudited financial statements for the year ended December 31, 2015, and its unaudited
financial statements for the six (6) months ended June 30, 2016 (collectively, “FMS Financial Statements”). The FMS
Financial Statements were prepared in accordance with GAAP applied on a consistent basis throughout the periods involved (except
as may be indicated in the notes thereto). Such financial statements present the financial position of FMS as at the dates thereof
and the results of its operations and its cash flows for the periods then ended.

 

b.            Except
as disclosed in the FMS Financial Statements or on Schedule 2.3 hereof, there has been no material change in the financial condition,
operations or business of FMS since June 30, 2016.

 

c.            Except
as otherwise disclosed in the FMS Financial Statements, FMS does not have any material liabilities.

 

2.4          Intellectual
Property And Intangible Assets. FMS has full legal right, title and interest in and to all of the intellectual property utilized
in the operation of its business, including but not limited to the Source Code referred to in Article 1.6 of this Agreement. No
rights of any other person are violated by the use by FMS of the intellectual property. Except as set forth on Schedule 2.4,
none of the intellectual property has ever been declared invalid or unenforceable, or is the subject of any pending or, threatened
action for opposition, cancellation, declaration, infringement, or invalidity, unenforceability or misappropriation or like claim,
action or proceeding.

 

2.5          Litigation.
There is no action, suit, investigation, audit or proceeding pending against, or to FMS’s knowledge threatened against or
affecting, FMS or any of its assets or properties before any court or arbitrator or any governmental body, agency or official.

 

2.6          Interested
Party Transactions. Except as disclosed in the FMS Financial Statements, FMS is not indebted to any officer or director of
FMS (except for compensation and reimbursement of expenses incurred in the ordinary course of business), and no such person is
indebted to FMS.

 

2.7          Compliance
With Applicable Laws. The business of FMS has not been, and is not being, conducted in violation of any law, except for possible
violations which individually or in the aggregate have not had and are not reasonably likely to have a material adverse effect
on FMS. No investigation or review by any governmental entity with respect to FMS is pending nor to FMS’s knowledge has any
governmental entity indicated an intention to conduct the same, except for investigations or reviews, which, individually or in
the aggregate, would not have, nor be reasonably likely to have, a material adverse effect on FMS.

 

2.8          No
Undisclosed Liabilities. Except as set forth in the FMS Financial Statements, there are no liabilities or debts of FMS of any
kind whatsoever except for trade payables incurred in the ordinary course of business, whether accrued, contingent, absolute, determined,
determinable or otherwise, and to FMS’s knowledge, there is no existing condition, situation or set of circumstances, which
could reasonably be expected to result in such a liability or debt.

 

    	5 

    	 

    

 

2.9          Tax
Returns And Payment. FMS has duly and timely filed all tax returns required to be filed by it and has duly and timely paid
all taxes shown thereon to be due, except as reflected in the FMS Financial Statements and except for taxes being contested in
good faith. Except as disclosed in the FMS Financial Statements, there is no material claim for taxes that is a Lien against the
property of FMS other than liens for taxes not yet due and payable, none of which taxes is material. FMS has not received written
notification of any audit of any tax return of FMS being conducted or pending by a tax authority where an adverse determination
could have a material adverse effect on FMS, no extension or waiver of the statute of limitations on the assessment of any taxes
has been granted by FMS which is currently in effect, and FMS is not a party to any agreement, contract or arrangement with any
tax authority or otherwise, which may result in the payment of any material amount in excess of the amount reflected on the FMS
Financial Statements.

 

2.10        Title
And Related Matters. FMS has good and marketable title to all of its properties, inventory, interests in properties, and assets,
real and personal, which are reflected in the most recent balance sheet in the FMS Financial Statements or acquired after that
date (except properties, interests in properties, and assets sold or otherwise disposed of since such date in the ordinary course
of business). FMS owns, free and clear of any liens, any and all of its assets.

 

2.11        Finders.
Any liability to any broker, finder, or agent for fees or commissions in connection with this Agreement and the transactions contemplated
hereby shall be the sole responsibility of the FMS Shareholder and shall be paid and satisfied at or before Closing.

 

2.12        FMS’s
Knowledge. Use of the qualifying term “knowledge” in any representations in this Section 2 shall mean actual knowledge
with respect to which such representation is made, but does not include, except as specifically provided, constructive knowledge.
Notwithstanding the foregoing, such term requires a reasonable examination of files, records, and materials to ascertain whether
the same reveal any facts that are relevant to the representation in question.

 

ARTICLE III 

REPRESENTATIONS AND
WARRANTIES OF EMR

 

Except as set forth
in the schedules to this Agreement, disclosure in any one of which shall apply to any and all representations and warranties made
in this Agreement, EMR hereby represents and warrants to FMS and the FMS Shareholder , as of the date of this Agreement and as
of the Effective Time (except as otherwise indicated), as follows:

 

3.1          Organization,
Standing and Power. EMR is a corporation duly incorporated, validly existing and in good standing under the laws of the State
of Nevada. It has full corporate power and authority to conduct its business as presently conducted and to enter into and perform
this Agreement and to carry out the transactions contemplated by this Agreement. The execution and delivery of this Agreement,
the execution and delivery of each Closing Document to which EMR is a party, and the performance by EMR of its obligations thereunder,
are within the powers of EMR, and have been authorized by all necessary action properly taken, have received all necessary governmental
approvals, if any were required, and do not contravene or conflict with any current provision of any material
law, any applicable judgment, ordinance, regulation or order of any court or governmental agency, the Articles of Incorporation,
By-Laws and Shareholder Agreement of EMR or any agreement binding upon EMR. The EMR officer(s) executing this Agreement, the Note,
and all other Closing Documents is/are duly authorized to act on behalf of EMR.

 

    	6 

    	 

    

 

3.2          Capitalization.
There are Seventy Million (70,000,000) shares of EMR capital stock authorized, consisting entirely of common stock, par value
($.001) per share (the “EMR Shares”). As of the date of this Agreement, there were 4,631,752 issued and outstanding
EMR Shares, excluding any shares issued to the FMS Shareholder at the Closing in connection with this Agreement. Except as set
forth in Schedule 3.2, no EMR Shares have been reserved for issuance to any person, and there are no outstanding rights,
warrants, options or agreements for the purchase of EMR Shares. The EMR Shares have been issued in compliance with all applicable
laws.

 

3.3          Litigation.
There is no action, suit, investigation, audit or proceeding pending against or threatened, against or affecting EMR or any of
its material assets or properties before any court or arbitrator or any governmental body, agency or official.

 

3.4          Compliance
With Applicable Laws. The business of EMR has not been, and is not being, conducted in violation of any applicable law, except
for possible violations, which individually or in the aggregate, have not had and are not reasonably likely to have a material
adverse effect on EMR. No investigation or review by any governmental entity with respect to EMR is pending or threatened, nor
has any governmental entity indicated an intention to conduct the same, except for investigations or reviews that, individually
or in the aggregate, would not have, nor be reasonably likely to have, a material adverse effect on EMR.

 

3.5          Tax
Returns and Payment. EMR has duly and timely filed all tax returns required to be filed by it and has duly and timely paid
all taxes shown thereon to be due, except as reflected in the EMR Financial Statements and except for taxes being contested in
good faith. Except as disclosed in the EMR Financial Statements, there is no material claim for taxes that is a lien against the
property of EMR other than liens for taxes not yet due and payable, none of which taxes is material. EMR has not received written
notification of any audit of any tax return of EMR being conducted or pending by a tax authority where an adverse determination
could have a material adverse effect on EMR, no extension or waiver of the statute of limitations on the assessment of any taxes
has been granted by EMR which is currently in effect, and EMR is not a party to any agreement, contract or arrangement with any
tax authority or otherwise, which may result in the payment of any material amount in excess of the amount reflected on the EMR
Financial Statements.

 

3.6          No
Undisclosed Liabilities - EMR. Except as set forth on Schedule 3.6 there are no liabilities or debts of EMR of any kind
whatsoever, whether accrued, contingent, absolute, determined, determinable or otherwise, and there is no existing condition, situation
or set of circumstances that could reasonably be expected to result in such a liability or debt.

 

    	7 

    	 

    

 

ARTICLE IV 

CERTAIN COVENANTS AND AGREEMENTS

 

4.1          Covenants
of FMS. FMS covenants and agrees that, during the period from the date of this Agreement until the Closing Date, FMS shall
conduct its business as presently operated and solely in the ordinary course, and, without the written consent of EMR:

 

a.            shall
not amend its Certificate of Incorporation or Bylaws;

 

b.            shall
not pay or agree to pay to any employee, officer or director compensation that is in excess of the current compensation level of
such employee, officer or director other than salary increases or payments made in the ordinary course of business;

 

c.            shall
not merge or consolidate with any other entity or acquire or agree to acquire any other entity;

 

d.            shall
not sell, transfer, or otherwise dispose of any material assets required for the operations of FMS’s business except in the
ordinary course of business consistent with past practices;

 

e.            shall
not create, incur, assume, or guarantee any material indebtedness for money borrowed except in the ordinary course of business,
or create or suffer to exist any mortgage, lien or other encumbrance on any of its material assets, except those in existence on
the date hereof;

 

f.             shall
not make any material capital expenditure or series of capital expenditures except in the ordinary course of business;

 

g.            shall
not declare or pay any dividends on or make any distribution of any kind with respect to the FMS Shares;

 

h.            shall
notify EMR promptly in the event of any material loss or damage to any of FMS’s material assets;

 

i.             shall
pay premiums in respect of all present insurance coverage of the types and in the amounts as are in effect as of the date of this
Agreement;

 

j.             shall
use reasonable efforts to preserve the present material employees, reputation and business organization of FMS its relationships
with its significant clients and others having business dealings with it;

 

k.            shall
not issue any additional shares of FMS capital stock or take any action affecting the capitalization of FMS or the FMS Shares;
and

 

l.             shall
not enter into any material contract or commitment other than in the ordinary course of business.

 

    	8 

    	 

    

 

4.2          Covenants
of EMR. EMR covenants and agrees that, during the period from the date of this Agreement until the Closing Date, without the
written consent of FMS, EMR:

 

a.            shall
not amend its Certificate of Incorporation or Bylaws;

 

b.            shall
not declare or pay any dividends on or make any distribution of any kind with respect to the shares of capital stock of EMR.

 

4.3          Announcements.
Neither EMR nor FMS shall issue any press release or otherwise make any public statement with respect to this Agreement or the
transactions contemplated hereby without the prior consent of the other party (which consent shall not be unreasonably withheld),
except as may be required by applicable law or securities regulation. Notwithstanding anything in this Section 4.3 to the contrary,
the parties will, to the extent practicable, consult with each other before issuing, and provide each other the opportunity to
review and comment upon, any such press release or other public statements with respect to this Agreement and the transactions
contemplated hereby whether or not required by applicable law.

 

ARTICLE V

CONDITIONS PRECEDENT

 

5.1          Conditions
Precedent To The Parties’ Obligations. The obligations of the parties as provided herein shall be subject to each of the following
conditions precedent, unless waived in writing by both EMR and FMS:

 

a.            Shareholder
Approval. FMS shall have obtained the requisite approval by its shareholders of this Agreement and the transactions contemplated
hereby.

 

b.            Absence
of Certain Litigation. No action or proceeding shall be threatened or pending before any governmental entity or authority which,
in the reasonable opinion of counsel for the parties, is likely to result in a restraint, prohibition or the obtaining of damages
or other relief in connection with this agreement or the consummation of the Purchase.

 

5.2          Conditions
Precedent to the Obligations of EMR. The obligations of EMR on the Closing Date as provided herein shall be subject to the
satisfaction, on or prior to the Closing Date, of the following conditions precedent, unless waived in writing by EMR:

 

a.            Representations
and Warranties. EMR shall have received a certification signed by the Chief Executive Officer and the Chief Financial Officer
of FMS attesting that the representations and warranties by FMS in Article II herein are true and accurate in all material respects
on and as of the Closing Date with the same force and effect as though such representations and warranties had been made at and
as of the Closing Date.

 

b.            Performance.
FMS shall have performed and complied in all material respects with all agreements to be performed or complied with by it pursuant
to this Agreement at or prior to the Closing.

 

    	9 

    	 

    

 

c.            Certificate
of Good Standing. FMS shall have delivered to EMR a certificate as to the good standing of FMS certified by the Secretary of
State of the State of Florida on or within five (5) business days prior to the Closing Date.

 

5.3          Conditions
Precedent To The Obligations of the FMS Shareholder. The obligations of the FMS Shareholder on the Closing Date as provided
herein shall be subject to the satisfaction, on or prior to the Closing Date, of the following conditions precedent, unless waived
in writing by the FMS Shareholder:

 

a.            Representations
And Warranties. The FMS Shareholder shall have received a certification signed by the Chief Executive Officer and the Chief
Financial Officer of EMR attesting that the representations and warranties by EMR in Article III herein are true and accurate in
all material respects on and as of the Closing Date with the same force and effect as though such representations and warranties
had been made at and as of the Closing Date.

 

b.            Performance.
EMR shall have performed and complied in all material respects with all agreements to be performed or complied with by it pursuant
to this Agreement prior to or at the Closing.

 

c.            Certificate
of Good Standing. EMR shall have delivered to FMS a certificate as to the good standing of certified by the Secretary of State
of the State of Nevada on or within thirty (30) business days prior to the Closing Date.

 

ARTICLE VI

TERMINATION

 

6.1          Termination.
This Agreement may be terminated and the Purchase may be abandoned at any time prior to the Effective Time by:

 

a.            The
mutual written consent of the Boards of Directors of the parties;

 

b.            Either
party if any governmental entity or court of competent jurisdiction shall have issued an order, decree or ruling or taken any other
action (which order, decree, ruling or other action the parties shall use their commercially reasonable best efforts to lift),
which restrains, enjoins or otherwise prohibits the Purchase and such order, decree, ruling or other action shall have become final
and non-appealable;

 

c.            EMR,
if FMS or the FMS Shareholder shall have breached in any material respect any of its representations, warranties, covenants or
other agreements contained in this Agreement, and the breach cannot be or has not been cured within thirty (30) calendar days after
the giving of written notice by EMR to the FMS Shareholder;

 

d.            FMS
or the FMS Shareholder, if EMR shall have breached in any material respect any of its representations, warranties, covenants or
other agreements contained in this Agreement, and the breach cannot be or has not been cured within thirty (30) calendar days after
the giving of written notice by FMS or the FMS Shareholder to EMR.

 

    	10 

    	 

    

 

6.2          Effect
of Termination. If this Agreement is terminated as provided in Section 6.1, written notice of such termination shall be given
by the terminating party to the other party specifying the provision of this Agreement pursuant to which such termination is made,
this Agreement shall become null and void and there shall be no liability on the part of EMR, FMS or the FMS Shareholder, provided
that nothing in this Agreement shall relieve any party from any liability or obligation with respect to any willful breach of this
Agreement and provided further that termination shall not affect accrued rights or liabilities of any party at the time of such
termination.

 

ARTICLE VII 

CONFIDENTIALITY

 

EMR, on the one hand,
and the FMS Shareholder, on the other hand, will keep confidential all information and documents obtained from the other, including
but not limited to any information or documents provided pursuant to this Agreement that are designated by such party as confidential
(except for any information disclosed to the public pursuant to a press release authorized by the parties) and in the event the
Closing does not occur or this Agreement is terminated for any reason, will promptly return such documents and all copies of such
documents and all notes and other evidence thereof, including material stored on a computer, and will not use such information
for its own advantage, except to the extent that (i) the information must be disclosed by law, (ii) the information becomes publicly
available by reason other than disclosure by the party subject to the confidentiality obligation, (iii) the information is independently
developed without use of or reference to the other party’s confidential information, (iv) the information is obtained from
another source not obligated to keep such information confidential, (v) the information is already publicly known or known to the
receiving party when disclosed as demonstrated by written documentation in the possession of such party at such time, or (vi) in
connection with any arbitration proceeding hereunder.

 

ARTICLE VIII

MISCELLANEOUS

 

8.1          Applicable
Law, Venue. This Agreement shall be governed by the laws of the State of New Jersey, without giving effect to the principles
of conflicts of laws thereof, as applied to agreements entered into and to be performed in such state. Any and all disputes arising
under this Agreement shall be resolved in litigation venued in the federal and/or state courts located in the State of New Jersey.

 

8.2          Notices.
All notices and other communications under this Agreement shall be in writing and shall be deemed to have been duly given or made
as follows:

 

a.            If
sent by reputable overnight air courier (such as Federal Express), one business day after being sent;

 

b.            If
sent by facsimile transmission, with a copy shipped on the same day in the manner provided in clause (a) above, when transmitted
and receipt is confirmed by the fax machine; or

 

    	11 

    	 

    

 

c.            If otherwise actually personally delivered, when delivered.

 

All notices and other communications under
this Agreement shall be sent or delivered as follows:

 

If to FMS or to the FMS Shareholder, to:

 

Denis Salins, President

c/o First Medical Solutions
Corporation

6524 NW 55th
Street,

Coral
Springs, Florida 33067

Email: denis.salins@gmail.com

 

with a copy to (which shall not
constitute notice):

 

Marc I. Solomon, Esq.

Weiss Serota
Helfman Cole & Bierman

200 E. Broward Blvd.

Suite 1900

Fort Lauderdale, Florida
33301

Facsimile: (954) 764-7770

 

If to EMR, to:

 

John X. Adiletta

EMR Technology Solutions, Inc.

90 Washington
Valley Road

Bedminster, NJ 07921

Facsimile: (908) 953-0797

 

with a copy to (which shall not
constitute notice):

 

William R. McClure, Esq.

Picinich & McClure

201 W.
Passaic Street, Suite 204

Rochelle Park, NJ 07662

Facsimile: (201) 820-4594

 

Each Party may change its address by written
notice in accordance with this Section.

 

8.3          Entire
Agreement. This Agreement (including the documents and instruments referred to in this Agreement) contains the entire understanding
of the parties with respect to the subject matter contained in this Agreement, and supersedes and cancels all prior agreements,
negotiations, correspondence, undertakings and communications of the parties, oral or written, respecting such subject matter.

 

    	12 

    	 

    

 

IN WITNESS WHEREOF, the parties
have made this Agreement as of the date set forth on the first page.

 

	EMR TECHNOLOGY SOLUTIONS, INC.	 	FIRST MEDICAL SOLUTIONS CORPORATION
	 	 	 	 	 
	By:	/s/ John X. Adiletta	 	By:	/s/ Denis Salins
	Name:	John X. Adiletta	 	Name:	Denis Salins
	Title:	Chief Executive Officer	 	Title:	President
	 	 	 	 	 

 

    	13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]